Clinical Trial
doi: 10.1097/00005344-197907000-00001.
Evaluation of indapamide in the treatment of hypertension
- PMID: 94616
- DOI: 10.1097/00005344-197907000-00001
Item in Clipboard
Clinical Trial
Evaluation of indapamide in the treatment of hypertension
J Cardiovasc Pharmacol.
1979 Jul-Aug.
Abstract
A randomized double-blind, crossover trial was carried out in twenty hypertensive patients to evaluate the hypotensive efficacy and safety of indapamide. Indapamide in doses of 2.5 mg per day in combination with other antihypertensive agents was as effective in reducing the blood pressure in hypertensive patients as one tablet of Moduretic (50 mg hydrochlorothiazide and 5 mg amiloride). Indapamide induced no changes in serum potassium or uric acid levels and there were no major side effects.
Similar articles
-
Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension.Cardiovasc Drugs Ther. 1989 Apr;3(2):141-4. doi: 10.1007/BF01883857. Cardiovasc Drugs Ther. 1989. PMID: 2487529 Clinical Trial.
-
Clinical efficacy and safety of indapamide in essential hypertension.Am Heart J. 1983 Jul;106(1 Pt 2):229-32. doi: 10.1016/0002-8703(83)90121-7. Am Heart J. 1983. PMID: 6346846 Clinical Trial.
-
Indapamide in the treatment of essential arterial hypertension: results of a controlled study.Curr Med Res Opin. 1983;8 Suppl 3:59-66. doi: 10.1185/03007998309109837. Curr Med Res Opin. 1983. PMID: 6352186 Clinical Trial.
-
Evidence-based diuretics: focus on chlorthalidone and indapamide.Future Cardiol. 2015 Mar;11(2):203-17. doi: 10.2217/fca.14.83. Future Cardiol. 2015. PMID: 25760879 Review.
-
Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.J Hypertens. 2018 Jun;36(6):1247-1255. doi: 10.1097/HJH.0000000000001691. J Hypertens. 2018. PMID: 29465713
Cited by
-
Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.Drugs. 1984 Sep;28(3):189-235. doi: 10.2165/00003495-198428030-00001. Drugs. 1984. PMID: 6489195
-
Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.Eur J Clin Pharmacol. 1982;22(3):191-6. doi: 10.1007/BF00545213. Eur J Clin Pharmacol. 1982. PMID: 7049706 Clinical Trial.
-
Pharmacokinetics and bioavailability of indapamide--a new antihypertensive drug.Eur J Clin Pharmacol. 1982;22(4):295-9. doi: 10.1007/BF00548396. Eur J Clin Pharmacol. 1982. PMID: 7106164 Clinical Trial.
-
Indapamide and bendrofluazide: a comparison in the management of essential hypertension.Br J Clin Pharmacol. 1981 Dec;12(6):883-6. doi: 10.1111/j.1365-2125.1981.tb01325.x. Br J Clin Pharmacol. 1981. PMID: 7041937 Free PMC article. Clinical Trial.
-
Ventricular fibrillation induced by xipamide.Br Med J (Clin Res Ed). 1982 Feb 13;284(6314):494. doi: 10.1136/bmj.284.6314.494. Br Med J (Clin Res Ed). 1982. PMID: 6800510 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources